Repeat Ablation of Persistent Atrial Fibrillation, Including Mitral Isthmus Catheter Ablation, With the FARAPULSE Pulsed Field Ablation System
A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 376 participants.
Also called NCT06735534
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 376 participants
- Sponsor
- Registry
-
NCT06735534
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States, Australia, Taiwan
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT06735534. Allocation not applicable; no masking; primary purpose treatment. Start 2025-06-03 (actual); primary completion 2027-04 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Repeat Ablation of Persistent Atrial Fibrillation, Including Mitral Isthmus Catheter Ablation, With the FARAPULSE Pulsed Field Ablation System
- Acronym
- ReMATCH
- Condition
- Persistent Atrial Fibrillation
- Intervention (Device)
- FARAPULSE™ Pulsed Field Ablation System
- Lead sponsor
- Boston Scientific Corporation
Record details
- Record id
cardio:ct-nct06735534- Content hash
af66369769d333d2acb575be4cfe81f16c1f1fdc45a6bb453b03fd1aef4c2a5c